Oblong (OBLG) 10-Q 29 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Jun. 25, 2020
Document and Entity Information
Entity Registrant Name	OBLONG, INC.
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Reporting Status	Yes
Smaller Reporting Company	true
Emerging Growth Company	false
Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		5,226,879

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 2,059	$ 4,602
Inventory	1,439	1,816
Accounts receivable, net	4,209	2,543
Prepaid expenses and other current assets	1,098	965
Total current assets	8,805	9,926
Property and equipment, net	1,091	1,316
Goodwill	7,366	7,907
Intangibles, net	11,961	12,572
Operating lease - right of use asset, net	2,602	3,117
Other assets	128	71
Total assets	31,953	34,909
Current liabilities:
Current portion of long-term debt, net of discount	3,550	2,664
Accounts payable	921	647
Accrued expenses and other current liabilities	1,262	1,752
Deferred revenue	2,673	1,901
Current portion of operating lease liabilities	1,294	1,294
Total current liabilities	9,700	8,258
Long-term liabilities:
Long-term debt, net of current portion and net of discount	1,991	2,843
Operating lease liabilities, net of current portion	1,487	2,020
Other long-term liabilities	0	3
Total long-term liabilities	3,478	4,866
Total liabilities	13,178	13,124
Commitments and contingencies (see Note 13)
Stockholders’ equity:
Common stock, $.0001 par value; 150,000,000 shares authorized; 5,316,828 shares issued and 5,211,543 outstanding at March 31, 2020 and 5,266,828 shares issued and 5,161,543 outstanding at December 31, 2019	1	1
Treasury stock, 105,285 shares at March 31, 2020 and December 31, 2019	(172)	(165)
Additional paid-in capital	207,509	207,383
Accumulated deficit	(188,563)	(185,434)
Total stockholders’ equity	18,775	21,785
Total liabilities and stockholders’ equity	31,953	34,909
Series A-2 Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series C Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series D Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series E Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Preferred stock, convertible, shares authorized (in shares)	5,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	5,316,828	5,266,828
Common stock, shares outstanding (in shares)	5,211,543	5,161,543
Treasury stock, shares (in shares)	105,285	105,285
Series A-2 Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 7,500	$ 7,500
Preferred stock, convertible, shares authorized (in shares)	7,500	7,500
Preferred stock, convertible, shares issued (in shares)	45	32
Preferred stock, convertible, shares outstanding (in shares)	45	32
Preferred stock, convertible, liquidation value	$ 336,000	$ 237,000
Series C Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 1,000	$ 1,000
Preferred stock, convertible, shares authorized (in shares)	1,750	1,750
Preferred stock, convertible, shares issued (in shares)	325	475
Preferred stock, convertible, shares outstanding (in shares)	325	475
Preferred stock, convertible, liquidation value	$ 325,000	$ 475,000
Series D Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	1,750,000	1,750,000
Preferred stock, convertible, shares issued (in shares)	1,720,460	1,734,901
Preferred stock, convertible, shares outstanding (in shares)	1,720,460	1,734,901
Preferred stock, convertible, liquidation value	$ 49,163,000	$ 49,445,000
Series E Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	175,000	175,000
Preferred stock, convertible, shares issued (in shares)	131,579	131,579
Preferred stock, convertible, shares outstanding (in shares)	131,579	131,579
Preferred stock, convertible, liquidation value	$ 3,750,000	$ 3,750,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue	$ 5,328	$ 2,594
Cost of revenue (exclusive of depreciation and amortization)	2,374	1,675
Gross profit	2,954	919
Operating expenses:
Research and development	1,327	213
Sales and marketing	1,220	33
General and administrative	2,028	1,112
Impairment charges	541	0
Depreciation and amortization	815	159
Operating Expenses	5,931	1,517
Loss from operations	(2,977)	(598)
Interest and other expense, net	(154)	0
Foreign exchange gain	2	0
Interest and other expense, net	(152)	0
Net loss	(3,129)	(598)
Preferred stock dividends	4	15
Net loss attributable to common stockholders	$ (3,133)	$ (613)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share (in dollars per share)	$ (0.60)	$ (0.12)
Weighted-average number of shares of common stock:
Basic and diluted (in shares)	5,204	5,104

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A-2 Preferred Stock	Preferred StockSeries A-2 Preferred Stock	Preferred StockSeries B Preferred Stock	Preferred StockSeries C Preferred Stock	Preferred StockSeries D Preferred Stock	Preferred StockSeries E Preferred Stock	Common Stock	Common StockSeries C Preferred Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2018			32	75	525			5,113,726		132,519
Beginning Balance, value at Dec. 31, 2018	$ 6,830		$ 0	$ 0	$ 0			$ 1		$ (496)	$ 184,998	$ (177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(598)											(598)
Stock-based compensation	29										29
Preferred stock conversion (in shares)				(75)	(50)			(43,402)
Issuance of stock on vested restricted stock units (in shares)								16,824
Preferred stock dividends	(15)										(15)
Issuance of preferred stock for accrued dividends (in shares)			13
Purchase of treasury stock (in shares)										900
Purchase of treasury stock	(1)									$ (1)
Ending Balance (in shares) at Mar. 31, 2019			32	0	475			5,173,952		133,419
Ending Balance, value at Mar. 31, 2019	6,245		$ 0	$ 0	$ 0			$ 1		$ (497)	185,012	(178,271)
Beginning Balance (in shares) at Dec. 31, 2018			32	75	525			5,113,726		132,519
Beginning Balance, value at Dec. 31, 2018	$ 6,830		$ 0	$ 0	$ 0			$ 1		$ (496)	184,998	(177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock conversion (in shares)					(50)				(16,667)
Forfeited restricted stock (in shares)	10,063
Ending Balance (in shares) at Dec. 31, 2019			32		475	1,734,901	131,579	5,266,828		105,285
Ending Balance, value at Dec. 31, 2019	$ 21,785		$ 0		$ 0	$ 0	$ 0	$ 1		$ (165)	207,383	(185,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,129)											(3,129)
Stock-based compensation	32										32
Preferred stock conversion (in shares)		(13)			(150)			(50,000)	(50,000)
Forfeited restricted stock (in shares)						(14,441)
Preferred stock dividends	(4)										(4)
Issuance of preferred stock for accrued dividends	98										98
Purchase of treasury stock	(7)									$ (7)
Ending Balance (in shares) at Mar. 31, 2020			45		325	1,720,460	131,579	5,316,828		105,285
Ending Balance, value at Mar. 31, 2020	$ 18,775		$ 0		$ 0	$ 0	$ 0	$ 1		$ (172)	$ 207,509	$ (188,563)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,129)	$ (598)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	815	159
Bad debt expense	13	(4)
Amortization of debt discount	34	0
Amortization of right of use asset	302
Payments on lease liability	(317)
Loss on disposal of equipment	22	0
Stock-based compensation	32	29
Impairment charges	541	0
Changes in operating assets and liabilities:
Accounts receivable	(1,679)	(67)
Inventory	377	0
Prepaid expenses and other current assets	(133)	(72)
Other assets	(59)	24
Accounts payable	274	(15)
Accrued expenses and other current liabilities	(398)	136
Deferred revenue	772	0
Other liabilities	(3)	0
Net cash used in operating activities	(2,536)	(408)
Cash flows from investing activities:
Purchases of property and equipment	0	(9)
Net cash used in investing activities	0	(9)
Cash flows from financing activities:
Preferred stock dividends	0	0
Purchase of treasury stock	7	1
Net cash used in financing activities	(7)	(1)
Decrease in cash and cash equivalents	(2,543)	(418)
Cash at beginning of period	4,602	2,007
Cash at end of period	2,059	1,589
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	90	0
Non-cash investing and financing activities:
Accrued preferred stock dividends	4	15
Issue of preferred stock in exchange for accrued dividends	$ 98	$ 0

Business Description and Signif

Business Description and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Business Description and Significant Accounting Policies	Business Description and Significant Accounting Policies Business Description Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications. Prior to March 6, 2020, Oblong, Inc. was named Glowpoint, Inc. (“Glowpoint”). On March 6, 2020, Glowpoint changed its name to Oblong, Inc. On October 1, 2019, the Company closed an acquisition of all of the outstanding equity interest of Oblong Industries, Inc., a privately held Delaware corporation founded in 2006 (“Oblong Industries” and, such transaction, the “Acquisition”); see further discussion in Note 3 - Oblong Industries Acquisition . In this Report, we use the terms “Oblong” or “we” or “us” or the “Company” to refer to (i) Oblong (formerly Glowpoint), for periods prior to the closing of the Merger, and (ii) the “combined organization” of Oblong (formerly Glowpoint) and Oblong Industries for periods after the closing of the Merger. For purposes of segment reporting, we refer to the Oblong (formerly Glowpoint) business as “Glowpoint” herein, and to the Oblong Industries business as “Oblong Industries” herein. Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2019 . In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2019 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2019 and notes thereto included in the Company's fiscal 2019 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on May15, 2020 (the “ 2019 10-K”). The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. Because the closing of the acquisition of Oblong Industries occurred on October 1, 2019 , the Company’s condensed consolidated financial statements for the three months ended March 31, 2019 included in this Report do not reflect Oblong Industries’ financial results. Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, Inc., and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries. Segments Prior to the acquisition of Oblong Industries on October 1, 2019 , the Company operated in one segment. Following October 1, 2019 , the former businesses of Glowpoint and Oblong Industries have been managed separately and involve different products and services. Accordingly, the Company currently operates in two segments: 1) the Glowpoint (now named Oblong) business which includes managed services for video collaboration and network applications and 2) the Oblong Industries business which includes products and services for visual collaboration technologies. See Note 12 - Segment Reporting for further discussion. Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of property and equipment, and intangible assets, the inputs used in the fair value of equity based awards as well as the values ascribed to assets acquired and liabilities assumed in the business combination. Significant Accounting Policies The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2019 10-K. Leases The Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred. Treasury Stock Purchases and sales of treasury stock are accounted for using the cost method. Under this method, shares acquired are recorded at the acquisition price directly to the treasury stock account. Upon sale, the treasury stock account is reduced by the original acquisition price of the shares and any difference is recorded in equity, on a first-in first-out basis. The Company does not recognize a gain or loss to income from the purchase and sale of treasury stock. Recently Issued Accounting Pronouncements In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02 “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” Topic 326 introduces an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g. accounts receivable, loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. Topic 326 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact the new guidance will have on its consolidated financial statements.

Liquidity and Going Concern Unc

Liquidity and Going Concern Uncertainty	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Going Concern Uncertainty	Liquidity and Going Concern Uncertainty As of March 31, 2020 , we had $2,059,000 of cash, $5,609,000 of total obligations under the Silicon Valley Bank (“SVB”) Loan Agreement, and a working capital deficit of $895,000 . For the three months ended March 31, 2020 , we incurred a net loss of $3,129,000 and used $2,536,000 of net cash in operating activities. As of March 31, 2020, the SVB Loan Agreement provided that interest-only payments were due through March 31, 2020, after which equal monthly principal and interest payments were payable in order to fully repay the loan by September 1, 2021. On June 26, 2020, the Company and SVB entered into a Default Waiver and First Amendment (the “Amendment”) to the SVB Loan Agreement. Under the Amendment, the Bank agreed to extend the interest-only payment period under the Loan Agreement through September 30, 2020, after which equal monthly principal payments of $291,500 are payable over an eighteen-month period from October 1, 2020 through March 1, 2022 to fully repay the loan. See further discussion of the Amendment in Note 14 - Subsequent Events . In April 2020, we received cash proceeds from a loan for $2,416,600 (the “PPP Loan”) from MidFirst Bank under the Paycheck Protection Program (PPP) contained within the Coronavirus Aid, Relief, and Economic Security (CARES) Act (see Note 14 - Subsequent Events . The PPP Loan has a term of two years , is unsecured, and is guaranteed by the U.S. Small Business Administration (SBA). The PPP Loan carries a fixed interest rate of one percent ( 1.0% ) per annum, with the first six months of interest deferred. Our capital requirements in the future will continue to depend on numerous factors, including the timing and amount of revenue for the combined organization, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the combined organization’s major customers, the expense to deliver services, expense for sales and marketing, expense for research and development, capital expenditures, the cost involved in protecting intellectual property rights, debt service obligations under the SVB Loan Agreement, the amount of forgiveness of the PPP Loan, if any, and the debt service obligations under the PPP Loan, and expenses required to successfully integrate Glowpoint and Oblong Industries. While our acquisition of Oblong Industries does provide additional revenues to the Company, the cost to further develop and commercialize its product offerings is expected to exceed its revenues for the foreseeable future. We have achieved certain cost synergies in connection with combining Glowpoint and Oblong Industries; we reduced the total of general and administrative, research and development, sales, and marketing expenses by $1,081,000 or 19% from the fourth quarter of 2019 as compared to the first quarter of 2020 (or a total of $5,656,000 in the fourth quarter of 2019 as compared to $4,575,000 in the first quarter of 2020). We expect to further reduce the Company’s operating expenses in the future as compared to its annualized operating expenses for the three months ended March 31, 2020 . We also expect to continue to invest in product development and sales and marketing expenses with the goal of growing the Company’s revenue in the future. The Company believes that, based on the combined organization’s current projection of revenue, expenses, capital expenditures, debt service obligations, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to and raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments that might result from these uncertainties. See Note 13 - Commitments and Contingencies to our condensed consolidated financial statements for discussion regarding certain additional factors that could impact the Company’s liquidity in the future.

Oblong Industries Acquisition

Oblong Industries Acquisition	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Oblong Industries Acquisition	Note 3 - Oblong Industries Acquisition On October 1, 2019 (the “Closing Date”), the Company closed its acquisition of Oblong Industries, Inc. The acquisition was consummated through the merger of Glowpoint Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (the “Merger Sub”), with and into Oblong Industries on the Closing Date, with Oblong Industries continuing as the surviving corporation and as a wholly-owned subsidiary of the Company. The acquisition was accounted for in accordance with FASB Accounting Standards Codification Topic 805 “Business Combinations” (“ASC 805”) as a business combination, which requires an allocation of the purchase price of an acquired entity to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The purchase price and the fair value of the assets acquired and liabilities assumed were based on management estimates and values with assistance from an outside appraisal. Pursuant to ASC 805, the purchase price of $18,862,000 was measured as the fair value of the consideration exchanged in the acquisition. The Company acquired net assets of $11,496,000 , including $12,780,000 of identifiable intangible assets, in the acquisition. The purchase price exceeded the fair value of the net assets acquired by $7,366,000 , which was recorded as goodwill. The accompanying condensed consolidated financial statements do not include any revenues or expenses related to the Oblong Industries business on or prior to October 1, 2019 (the Closing Date of the Acquisition). The preliminary allocation of the purchase price was based upon a valuation for which the estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). The final allocation price could differ materially from the preliminary allocation. Any subsequent changes to the purchase price allocation that result in material changes to the Company’s consolidated financial results will be adjusted accordingly. The condensed consolidated statement of operations for the three months ended March 31, 2020 includes $3,283,000 of revenue and net loss of $2,234,000 related to Oblong Industries. The Company's unaudited pro forma results for the three months ended March 31, 2019 are summarized in the table below, assuming the Acquisition had occurred on January 1, 2019. These unaudited pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the results of operations which would have actually resulted had the acquisition occurred on January 1, 2019, nor to be indicative of future results of operations. Pro forma and unaudited (as if the acquisition of Oblong Industries had occurred on January 1, 2019) Three Months Ended March 31, 2019 ($ in thousands) Revenue Glowpoint $ 2,594 Oblong Industries 4,718 Pro forma total revenue $ 7,312 Net loss Glowpoint $ (598 ) Oblong Industries (3,592 ) Pro forma net loss $ (4,190 )

Inventory

Inventory	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Inventory	Inventory Inventory was $1,439,000 and $1,816,000 as of March 31, 2020 and December 31, 2019 , respectively, and consisted primarily of equipment related to our Mezzanine™ product offerings , including cameras, tracking hardware, computer equipment, display equipment and amounts related to the Oblong Industries business. Inventory consists of finished goods and was determined using average costs and was stated at the lower of cost or net realizable value. The Company periodically performs analyses to identify obsolete or slow-moving inventory, and any such amounts are written off to expense.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill As of March 31, 2020 and December 31, 2019, goodwill was $7,366,000 and $7,907,000 , respectively. As of March 31, 2020, goodwill was comprised of $7,366,000 recorded in connection with the October 1, 2019 acquisition of Oblong Industries. As of December 31, 2019, goodwill was comprised of (i) $7,366,000 recorded in connection with the October 1, 2019 acquisition of Oblong Industries and (ii) $541,000 related to the Glowpoint reporting unit as discussed below. We test goodwill for impairment on an annual basis on September 30 of each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. Following the acquisition of Oblong Industries, the Company operated two reporting units, Glowpoint and Oblong Industries. As of March 31, 2020, we considered the novel Coronavirus (COVID-19) pandemic and resulting declines in certain of the Company’s revenue to be a triggering event for an interim goodwill impairment test for both reporting units. To determine the fair value of each reporting unit, as of March 31, 2020 for the goodwill impairment tests, we used a weighted average of the discounted cash flow method and a market-based method (comparing the Company’s equity and analyzing multiples of revenue for comparable companies). For the Oblong Industries reporting unit, the fair value of the reporting unit exceeded its carrying amount, therefore no impairment charge was required. For the Glowpoint reporting unit, we recorded an impairment charge on goodwill of $541,000 for the three months ended March 31, 2020 as the carrying amount of the reporting unit exceeded its fair value on the test date. This charge is recognized as “Impairment Charges” on our condensed consolidated Statements of Operations. The activity in goodwill during the three months ended March 31, 2020 and the year ended December 31, 2019 is shown in the following table ($ in thousands): Goodwill Glowpoint Oblong Industries Total Balance December 31, 2018 $ 2,795 $ — $ 2,795 Impairment (2,254 ) — (2,254 ) Acquisition — 7,366 7,366 Balance December 31, 2019 541 7,366 7,907 Impairment (541 ) — (541 ) Balance March 31, 2020 $ — $ 7,366 $ 7,366 In the event we experience future declines in our revenue, cash flows and/or stock price, this may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of March 31, 2020 As of December 31, 2019 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Glowpoint Customer Relationships $ 4,335 $ (4,335 ) $ — $ 4,335 $ (4,335 ) $ — Affiliate network 994 (683 ) 311 994 (666 ) 328 Trademarks 548 (519 ) 29 548 (504 ) 44 Subtotal $ 5,877 $ (5,537 ) $ 340 $ 5,877 $ (5,505 ) $ 372 Oblong Industries Developed technology 10,060 (1,008 ) 9,052 10,060 (504 ) 9,556 Trade names 2,410 (120 ) 2,290 2,410 (60 ) 2,350 Distributor relationships 310 (31 ) 279 310 (16 ) 294 Subtotal $ 12,780 $ (1,159 ) $ 11,621 $ 12,780 $ (580 ) $ 12,200 Total $ 18,657 $ (6,696 ) $ 11,961 $ 18,657 $ (6,085 ) $ 12,572 As of March 31, 2020, we considered the novel Coronavirus (COVID-19) pandemic and resulting declines in certain of the Company’s revenue to be a triggering event for an interim impairment test of intangible assets for both reporting units. The fair value of each reporting unit’s intangible assets exceeded the respective carrying amounts, therefore no impairment charges were required for the three months ended March 31, 2020. Intangible assets with finite lives are amortized using the straight-line method over the estimated economic lives of the assets, which range from five years to twelve years in accordance with ASC Topic 350. The weighted average lives for the components of intangible assets are as follows: Glowpoint Affiliate network 12 Years Trademarks 8 Years Oblong Industries Developed technology 5 Years Trade names 10 Years Distributor relationships 5 Years Related amortization expense was $611,000 and $707,000 for the three months ended March 31, 2020 and the year ended December 31, 2019, respectively. Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2020 $ 1,820 2021 2,388 2022 2,386 2023 2,378 2024 1,844 Thereafter 1,145 Total $ 11,961

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	3 Months Ended
	Mar. 31, 2020
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Liabilities	Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): March 31, December 31, 2020 2019 Accrued compensation costs 596 810 Other accrued expenses and liabilities 661 843 Accrued dividends on Series A-2 Preferred Stock $ 5 $ 99 Accrued expenses and other liabilities $ 1,262 $ 1,752

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Note 8 - Debt Debt consisted of the following (in thousands): March 31, December 31, 2020 2019 Loan obligations $ 5,609 $ 5,609 Unamortized debt discounts (68 ) (102 ) Net carrying value 5,541 5,507 Less: current maturities, net of debt discount (3,550 ) (2,664 ) Long-term obligations, net of current maturities and debt discount $ 1,991 $ 2,843 Silicon Valley Bank Loan Agreement and Warrant On October 1, 2019, in connection with the Acquisition of Oblong Industries, the Company and Oblong Industries, as borrowers, and SVB, as lender, executed an amendment to the SVB Loan Agreement. On October 24, 2019, GP Communications joined the SVB Loan Agreement as an additional co-borrower. The SVB Loan Agreement provides for a term loan facility of approximately $5,247,000 , (the “Loan”), all of which is outstanding at December 31, 2019 and March 31, 2020. As of March 31, 2020, the SVB Loan Agreement provided that interest-only payments will be due through March 31, 2020, after which equal monthly principal and interest payments were payable in order to fully repay the Loan as of September 1, 2021. On June 26, 2020, the Company and SVB entered into a Default Waiver and First Amendment (the“Amendment”) to the SVB Loan Agreement. Under the Amendment, the Bank agreed to extend the interest-only payment period under the Loan Agreement through September 30, 2020, after which equal monthly principal payments of $291,500 are payable over an eighteen month period from October 1, 2020 through March 1, 2022 (the “Maturity Date”) to fully repay the loan. The Loan originally accrued interest at a rate equal to the Prime Rate (as defined in the SVB Loan Agreement) plus 200 basis points (for a total of 5.25% as of March 31, 2020 and 6.75% as of December 31, 2019). In connection with the Amendment, the interest rate under the Loan was increased to the Prime Rate plus 425 basis points. In connection with its execution of the amended SVB Loan Agreement on October 1, 2019, the Company i) agreed to pay SVB a fee of $100,000 on April 1, 2020 (the “Deferral Fee”) and ii) issued a warrant to SVB that entitles SVB to purchase 72,394 shares of the Company’s Common Stock at an exercise price of $0.01 per share (the “SVB Warrant”). Pursuant to the Amendment, the due date for the Deferral Fee was changed to the earlier of (i) the maturity of the loan, (ii) the repayment in full of all principal and interest owing under the Loan Agreement, and (iii) occurrence of an event of default under the Loan Agreement. The SVB Warrant has a ten ( 10 ) year term. The fair value of the SVB Warrant was recorded to additional paid-in capital and was determined to be $72,000 using the Black-Scholes model, with the following weighted-average assumptions: (i) risk-free interest rate of 1.5% , (iii) expected volatility of 143% and (iv) expected term of ten years. The total obligations under the SVB Loan Agreement are $5,609,000 , which are comprised of $5,247,000 for the term loan, the Deferral Fee and the Maturity Fee of $262,000 that was assumed on October 1, 2019 as part of the acquisition. The Deferral Fee, the fair value of the SVB Warrant, and $20,000 of debt issuance costs totaled $192,000 and was recorded as a discount to the debt. This debt discount is being amortized to interest expense using the effective interest method over the term of the debt. During the three months ended March 31, 2019 and the year ended December 31, 2019, the Company amortized $34,000 and $90,000 of the debt discount, respectively, which is recorded in “Interest and other expense, Net” on our condensed consolidated Statements of Operations. The remaining unamortized debt discount as of March 31, 2020 and December 31, 2019 was $68,000 and $102,000 , respectively. The obligations under the SVB Loan Agreement are secured by substantially all of the assets of Oblong and its subsidiaries. The SVB Loan Agreement contains certain restrictions and covenants, which, among other things, subject to certain exceptions, restrict the Company’s ability to dispose of any portion of its business or property, engage in certain material changes to its business, enter into a merger, incur additional debt or make guarantees, pay dividends or make distribution payments on, or redeem, retire, or repurchase any capital stock (subject to certain exceptions), create liens or other encumbrances, or enter into related party transactions outside of the ordinary course of business. The SVB Loan Agreement also contains customary events of default, including failure to pay any principal or interest when due, failure to perform or observe covenants, breaches of representations and warranties, certain cross defaults, certain bankruptcy related events, monetary judgments defaults and the Company’s de-listing from the NYSE American without a listing of its Common Stock on another nationally recognized stock exchange. Upon the occurrence of an event of default, the outstanding obligations under the SVB Loan Agreement may be accelerated and become immediately due and payable.

Preferred Stock

Preferred Stock	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Preferred Stock	Note 9 - Preferred Stock Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2020, there were: (i) 100 shares of Perpetual Series B-1 Preferred Stock authorized and no shares issued or outstanding; (ii) 7,500 shares of Series A-2 Convertible Preferred Stock authorized and 45 shares issued and outstanding (the “Series A-2 Preferred Stock”); (iii) 2,800 shares of 0% Series B Convertible Preferred Stock (“Series B Preferred Stock”) authorized and no shares issued and outstanding; (iv) 1,750 shares of 0% Series C Convertible Preferred Stock (“Series C Preferred Stock”) authorized and 325 shares issued and outstanding; (v) 4,000 shares of Series D Convertible Preferred Stock authorized and no shares issued or outstanding; (vi) 100 shares of Perpetual Series B Preferred Stock authorized and no shares issued or outstanding; (vii) 1,750,000 shares of Series D Preferred Stock authorized and 1,720,460 shares issued and outstanding; and (viii) 175,000 shares of 6.0% Series E Convertible Preferred Stock (“Series E Preferred Stock”) authorized and 131,579 shares issued and outstanding. Series A-2 Preferred Stock Each share of Series A-2 Preferred Stock has a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the Series A-2 Stated Value, and is convertible at the holder’s election into common stock at a conversion price per share of $21.60 as of March 31, 2020. Therefore, each share of Series A-2 Preferred Stock is convertible into 10,978 shares of common stock as of March 31, 2020. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation. The Series A-2 Preferred Stock is subordinate to the Series B-1 Preferred Stock and Series C-1 Preferred Stock but senior to all other classes of equity, has weighted average anti-dilution protection and, effective January 1, 2013, entitled to cumulative dividends at a rate of 5% per annum, payable quarterly, based on the Series A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of March 31, 2020 and December 31, 2020, the Company has recorded $5,000 and $99,000 , respectively, in accrued dividends on the accompanying condensed consolidated Balance Sheets related to the Series A-2 Preferred Stock outstanding. During the three months ended March 31, 2020, $98,000 , of accrued dividends, as of December 31, 2019, were exchanged for 13 shares of Series A-2 Preferred Stock. The Company, at its option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of $8,250 (equal to $7,500 per share multiplied by 110% ) plus all accrued and unpaid dividends. In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise could result in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and require a derivative liability. The Company determined no derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted $21.60 conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance that reduces the conversion price below the $11.16 fair value of the common stock on the issuance date of the Series A-2 Preferred Stock. Series C Preferred Stock On January 25, 2018, the Company closed a registered direct offering of 1,750 shares of its Series C Preferred Stock for total gross proceeds to the Company of $1,750,000 . The shares of Series C Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $3.00 per share. During the three months ended March 31, 2020 and the year ended December 31, 2019, 150 and 50 shares of Series C Preferred Stock were converted to 50,000 and 16,667 shares of the Company’s common stock, respectively. As of March 31, 2020 325 shares of Series C Preferred Stock remained issued and outstanding. The Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock. Series D Preferred Stock In connection with the Acquisition (see Note 3 - Oblong Industries Acquisition), the Company issued an aggregate of 1,686,659 shares of Series D Preferred Stock and an aggregate of 49,967 restricted shares of Series D Preferred Stock (“Restricted Series D Preferred Stock”), the latter of which are subject to vesting over a two -year period following the Closing Date of the Acquisition. Each share of Series D Preferred Stock is automatically convertible into a number of shares of the Company’s common stock equal to the accrued value of the share (initially $28.50 ), plus any accrued dividends thereon, divided by the Conversion Price (initially $2.85 per share, subject to specified adjustments) upon the completion of both (i) approval of such conversion by the Company’s stockholders (which occurred on December 19, 2019); and (ii) the receipt of all required authorizations and approval of a new listing application for the combined organization from the NYSE American. Pursuant to the terms of the Series D Certificate of Designations, each share of Series D Preferred Stock is entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series D Preferred Stock (or October 1, 2020). Prior to the first anniversary of the issuance of the Series D Preferred Stock no dividends will accrue on such stock. Dividends are cumulative and accrue daily in arrears. If the Company’s Board of Directors does not declare any applicable dividend payment in cash, the Accrued Value of the Series D Preferred Stock will be increased by the amount of such dividend payment. As of March 31, 2020, no dividends have been accrued. Series E Preferred Stock On October 1, 2019, Oblong entered into a Series E Preferred Stock Purchase Agreement (the “Purchase Agreement”) with the investors party thereto, who, prior to the closing of the Acquisition, were stockholders of Oblong Industries (the “Purchasers”), relating to the offer and sale by the Company in a private placement (the “Offering”) of up to 131,579 shares of its Series E Preferred Stock at a price of $28.50 per share. At an initial closing on October 1, 2019 and a subsequent closing on December 18, 2019, the Company sold a total of 131,579 shares of Series E Preferred Stock for net proceeds of approximately $3,750,000 . The 131,579 shares of Series E Preferred Stock issued by the Company in the Series E Financing have an aggregate Accrued Value of $3,750,000 and upon their conversion will convert at a conversion price of $2.85 per share into 1,315,790 common shares. Like the Series D Preferred Stock, each share of Series E Preferred Stock is automatically convertible into common stock upon the receipt of all required authorizations and approval of a new listing application for the combined organization from the NYSE American. Pursuant to the terms of the Series E Certificate of Designations, each share of Series E Preferred Stock is entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series E Preferred Stock (or October 1, 2020 or December 18, 2020, as applicable). Prior to the first anniversary of the issuance of the Series E Preferred Stock no dividends will accrue on such stock. Dividends are cumulative and accrue daily in arrears. If the Company’s Board of Directors does not declare any applicable dividend payment in cash, the Accrued Value of the Series E Preferred Stock will be increased by the amount of such dividend payment. As of March 31, 2020, no dividends have been accrued. In connection with the Purchase Agreement, the Company executed a Registration Rights Agreement, dated October 1, 2019 (the “Rights Agreement”). Pursuant to the Rights Agreement, among other things, the Company has provided the Purchasers with certain rights to require it to file and maintain the effectiveness of a registration statement with respect to the re-sale of shares of Common Stock underlying the shares of Series D Preferred Stock issued in the Oblong Transaction and Series E Preferred Stock sold in the Series E Financing. If the Series D and Series E Preferred Stock had been converted to common stock as of March 31, 2020, 17,204,600 and 1,315,790 shares of common stock would have been issued for the Series D and Series E Preferred Stock, respectively, which would have increased our outstanding shares of common stock from 5,211,543 to 23,731,933 . Both the Series D and Series E Preferred Stock remain outstanding as of March 31, 2020 and as of the filing of this Report. The Company intends to file a new listing application with the NYSE American as soon as possible upon satisfying the initial listing standards. Among other requirements, these standards require the Company to have at least $15 million of non-affiliate public float, which, under the Company’s current financial situation, may be difficult or impossible for the Company to satisfy.

Stock Based Compensation

Stock Based Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock Based Compensation	Note 10 - Stock Based Compensation 2019 Equity Incentive Plan On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. The 2019 Plan replaces the Glowpoint, Inc. 2014 Equity Incentive Plan (the “Prior Plan”), which was adopted by the Company’s Board of Directors on April 22, 2014, and subsequently approved by the Company’s stockholders. Following approval of the 2019 Plan, the Company terminated the Prior Plan and may no longer make grants under the Prior Plan; however, any outstanding equity awards granted under the Prior Plan will continue to be governed by the terms of the Prior Plan. As of the termination of the Prior Plan, 421,000 shares of the Company’s Common Stock remained available for issuance under the Prior Plan. As of March 31, 2020 , 23,334 restricted stock units were outstanding under the Prior Plan. As of March 31, 2020 , the share pool available for new grants under the 2019 Plan is 3,021,000 , which is equal to the sum of (i) 2,600,000 shares of the Company’s Common Stock and (ii) the 421,000 shares of the Company’s Common Stock that remained available for issuance under the Prior Plan. No equity awards were granted under the 2019 Plan during the three months ended March 31, 2020 . 2007 Stock Incentive Plan In May 2014, the Board terminated the Company’s 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect accordance with their terms. As of March 31, 2020 , options to purchase a total of 107,500 shares of common stock and 627 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan. Stock Options For the three months ended March 31, 2020 and the year ended December 31, 2019, other than the options granted to certain former holders of options to purchase shares of Oblong’s common stock, for which no stock-based compensation was recorded as discussed below, no stock options were granted. A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019 is presented below: Outstanding Exercisable Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price Options outstanding, December 31, 2018 118,003 $ 19.90 118,003 $ 19.90 Exchanged for Oblong Industries stock options 107,845 4.92 Exercised — — Expired (440 ) 16.48 Forfeited (10,063 ) 23.20 Options outstanding, December 31, 2019 215,345 12.27 215,345 12.27 Options outstanding and exercisable, March 31, 2020 215,345 $ 12.27 215,345 $ 12.27 Additional information as of March 31, 2020 is as follows: Outstanding and Exercisable Range of price Number of Options Weighted Average Remaining Contractual Life (In Years) Weighted Average Exercise Price $0.00 – $10.00 110,345 0.56 $ 5.01 $10.01 – $20.00 97,500 2.81 19.32 $20.01 – $30.00 2,500 2.19 21.80 $30.01 – $40.00 5,000 1.95 30.20 215,345 1.63 $ 12.27 In connection with the Acquisition, all options to purchase shares of Oblong’s common stock held by previously terminated employees of Oblong Industries were assumed by the Company and deemed, in the aggregate, to constitute options to acquire a total of 107,845 shares of the Company’s common stock, at a volume weighted average exercise price of $4.92 per share and a remaining exercise period of one year . No stock-based compensation expense was recorded in the year ended December 31, 2019 for these stock options as the value for these options was recorded as part of the consideration of the Acquisition given that these options were issued to terminated employees. The intrinsic value of vested options, unvested options and exercised options were no t significant for all periods presented. There was no remaining unrecognized stock-based compensation expense for options at March 31, 2020 as all options were vested. Restricted Stock Awards A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019, is presented below: Restricted Shares Weighted Average Grant Date Price Unvested restricted stock outstanding, December 31, 2018 11,320 $ 14.88 Granted 0 — Vested (1,372 ) 15.72 Forfeited (9,321 ) 14.70 Unvested restricted stock outstanding, December 31, 2019 627 15.80 Unvested restricted stock outstanding, March 31, 2020 627 $ 15.80 Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands): Three Months Ended March 31, Three Months Ended March 31, 2020 2019 General and administrative — 2 $ — $ 2 There is no unrecognized stock-based compensation expense for restricted stock awards at March 31, 2020 . Restricted Stock Units A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019, is presented below: Restricted Stock Units Weighted Average Grant Price Unvested restricted stock units outstanding, December 31, 2018 503,518 $ 1.94 Granted 55,479 1.30 Vested (114,505 ) 3.05 Forfeited (421,158 ) 1.54 Unvested restricted stock units outstanding, December 31, 2019 23,334 2.20 Unvested restricted stock units outstanding, March 31, 2020 23,334 $ 2.20 As of March 31, 2020 , 28,904 vested RSUs remain outstanding as shares of common stock have not yet been delivered for these units in accordance with the terms of the RSUs. As of March 31, 2020 , there were 11,667 unvested RSUs that have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, stock-based compensation expense is recognized over the relevant performance period. As of March 31, 2020 , there were 11,667 unvested RSUs that have timed-based vesting provisions, and the cost of the RSUs is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period. Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands): Three Months Ended March 31, Three Months Ended March 31, 2020 2019 Cost of revenue $ — $ 4 Research and development — 4 Sales and marketing — 19 General and administrative 6 27 $ 6 $ 54 There was no remaining unrecognized stock-based compensation expense for restricted stock units at March 31, 2020 . There was no tax benefit recognized for stock-based compensation expense for the three months ended March 31, 2020 or the year ended December 31, 2019. No compensation costs were capitalized as part of the cost of an asset during the periods presented. Restricted Series D Preferred Stock In connection with the Acquisition, all options to purchase shares of Oblong Industries’ common stock held by existing employees of Oblong Industries were canceled and exchanged for an aggregate of 49,967 restricted shares of Series D Preferred Stock (“Restricted Series D Preferred Stock”), which are subject to vesting over a two -year period following the Closing Date. Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended March 31, Three Months Ended March 31, 2020 2019 Research and development $ 14 $ — Sales and marketing 4 — General and administrative 8 — $ 26 $ — During the three months ended March 31, 2020 , 14,441 shares of Restricted Series D Preferred Stock were forfeited. As of March 31, 2020, 1,720,460 shares of Restricted Series D Preferred Stock remain outstanding. The remaining unrecognized stock-based compensation expense for Restricted Series D Preferred Stock at March 31, 2020 was $319,000 , and will be recognized over a weighted average period of 1.19 years .

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does no t include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2020 and 2019 , is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2020 and 2019 , all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss). The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended March 31, 2020 2019 Numerator: Net loss $ (3,129 ) $ (598 ) Less: preferred stock dividends (4 ) (15 ) Net loss attributable to common stockholders $ (3,133 ) $ (613 ) Denominator: Weighted-average number of shares of common stock for diluted net loss per share 5,204 5,104 Basic and diluted net loss per share $ (0.60 ) $ (0.12 ) The weighted-average number of shares for the three months ended March 31, 2020 and 2019 includes 28,904 and 98,763 shares of vested RSUs, respectively, as discussed in Note 10 - Stock Based Compensation . The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Three Months Ended March 31, 2020 2019 Unvested restricted stock units 23,334 539,394 Outstanding stock options 215,345 117,902 Unvested restricted stock awards 627 11,318 Shares of common stock issuable upon conversion of Series A-2 preferred stock 10,978 79,043 Shares of common stock issuable upon conversion of Series C preferred stock 108,333 158,333 Shares of common stock issuable upon conversion of Series D preferred stock 1,720,460 — Shares of common stock issuable upon conversion of Series E preferred stock 1,315,790 — Warrants 72,394 —

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Reporting	Note 12 - Segment Reporting Prior to the acquisition of Oblong Industries on October 1, 2019, the Company operated in one segment. Following October 1, 2019, the former businesses of Glowpoint and Oblong Industries were managed separately and involve different products and services. Accordingly, the Company currently operates in two segments: (1) the Glowpoint (now named Oblong) business which mainly consists of managed services for video collaboration and network applications; and (2) the Oblong Industries business which consists of products and services for visual collaboration technologies. Because the closing of the acquisition of Oblong Industries occurred on October 1, 2019, the Company’s condensed consolidated financial statements as of and for the three months ended March 31, 2020 and 2019 included in this Report only reflect Oblong Industries’ financial results for the first quarter of 2020. Certain information concerning the Company’s segments for the three months ended March 31, 2020 is presented in the following tables (in thousands): Three Months ended March 31, 2020 Glowpoint Oblong Industries Total Revenue $ 2,045 $ 3,283 $ 5,328 Cost of revenues 1,156 1,218 2,374 Gross profit $ 889 $ 2,065 $ 2,954 Gross profit % 43 % 63 % 55 % Allocated operating expenses $ 1,290 $ 2,073 $ 3,363 Unallocated operating expenses — — 2,568 Total operating expenses $ 1,290 $ 2,073 $ 5,931 Loss from operations $ (401 ) $ (8 ) $ (2,977 ) Interest and other expense, net — — (152 ) Net loss $ (401 ) $ (8 ) $ (3,129 ) As of March 31, 2020 Total assets $ 3,743 $ 28,210 $ 31,953 Unallocated operating expenses include costs for the three months ended March 31, 2020 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. Interest and other expense, net, is also not allocated to the operating segments. For the three months ended March 31, 2020 and 2019, there was no material revenue attributable to any individual foreign country. Approximately 1% of foreign revenue is billed in foreign currency and foreign currency gains and losses are not material. Revenue by geographic area is allocated as follows (in thousands): Three Months ended March 31, 2020 2019 Domestic $ 3,602 $ 1,796 Foreign 1,726 798 $ 5,328 $ 2,594 Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months ended March 31, 2020 % of Revenue 2019 % of Revenue Revenue: Glowpoint Video collaboration services $ 1,046 20 % $ 1,566 60 % Network services 925 17 % 965 37 % Professional and other services 74 1 % 63 2 % Total Glowpoint revenue $ 2,045 38 % $ 2,594 100 % Revenue: Oblong Industries Visual collaboration product offerings $ 2,322 44 % $ — — % Professional services 669 13 % — — % Licensing 292 5 % — — % Total Oblong Industries revenue $ 3,283 62 % $ — — % Total revenue $ 5,328 100 % $ 2,594 100 % Glowpoint’s fixed assets were 100% located in domestic markets during as of March 31, 2020 and December 31, 2019. Oblong Industries’ long-lived assets were located 81% in domestic and 19% in foreign markets as of March 31, 2020. The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations. Concentration of revenues was as follows: Three Months ended March 31, 2020 2019 Segment % of Revenue % of Revenue Customer A Glowpoint 11 % 21 % Customer B Glowpoint * 28 % Customer C Glowpoint * 10 % Customer D Oblong Industries 22 % — % * The amount did not exceed 10% of the Company’s consolidated total revenues. Concentration of accounts receivable was as follows: Three Months ended March 31, 2020 2019 Segment % of Accounts Receivable % of Accounts Receivable Customer A Glowpoint * 11 % Customer B Glowpoint * 48 % Customer C Glowpoint * * Customer D Glowpoint * 15 % Customer E Oblong Industries 42 % — % Customer F Oblong Industries 11 % — % * The amount did not exceed 10% of the Company’s consolidated total accounts receivable.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13 - Commitments and Contingencies Operating Leases We lease office and warehouse space in Los Angeles, California; Boston, Massachusetts; Atlanta, Georgia; Dallas, Texas; Los Altos, California; Herndon, Virginia; and Munich, Germany. These leases expire between October 2020 and 2023. Lease expense for the three months ended March 31, 2020 and 2019 were $316,000 and $52,000 , respectively. The Company primarily leases facilities for office and data center space under non-cancellable operating leases for its U.S. and international locations that expire at various dates through 2023. For leases with a term greater than 12 months, the Company recognizes a right-of-use asset and a lease liability based on the present value of lease payments over the lease term. Variable lease payments are not included in the lease payments to measure the lease liability and are expensed as incurred. The Company’s leases have remaining terms of one to four years and some of the leases include a Company option to extend the lease term for less than twelve months to five years , or more, which if reasonably certain to exercise, the Company includes in the determination of lease payments. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. As the Company's leases do not provide a readily determinable implicit rate, the Company uses the incremental borrowing rate at lease commencement, which was determined using a portfolio approach, based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses the implicit rate when a rate is readily determinable. Operating lease expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recognized on the balance sheet and the expense for these short-term leases is recognized on a straight-line basis over the lease term. Common area maintenance fees (or CAMs) and other charges related to these leases continue to be expensed as incurred. The following provides balance sheet information related to leases as of March 31, 2020 (in thousands): March 31, 2020 Assets Operating lease, right-of-use assets $ 2,602 Liabilities Operating lease liabilities, current $ 1,294 Operating lease liabilities, non-current 1,487 Total operating lease liabilities $ 2,781 The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2020 $ 981 2021 1,169 2022 716 2023 117 Total cash payments remaining $ 2,983 Effect of discounting (202 ) Total lease liability $ 2,781 On January 1, 2019, the Company recognized ROU assets and lease liabilities of approximately $99,000 and $111,000 , respectively, using an estimated incremental borrowing rate of 7.75% . On October 1, 2019 (the closing date of the acquisition of Oblong Industries), the Company recognized ROU assets and lease liabilities for Oblong Industries of approximately $3,376,000 and $3,578,000 , respectively, using an estimated incremental borrowing rate of 6.00% . The ROU assets and lease liabilities are recorded on the Company’s condensed consolidated balance sheet as of March 31, 2020 and December 31, 2019. During the three months ended March 31, 2020, non-cash immaterial out-of-period adjustments of approximately $195,000 were recorded to reduce the right of use asset and lease liability. These adjustments related to an error in the calculation of these amounts , in connection with the Oblong acquisition. Series A-2 Preferred Stock As discussed herein, on October 1, 2019, the Company closed its merger with Oblong Industries, in connection with which it became a co-borrower under the SVB Loan Agreement. Following consummation of the merger the Holder communicated to the Company his belief that the Company’s execution of the joinder to the SVB Loan Agreement without his consent contravened approval rights in the Series A-2 Certificate of Designations. The Company has not accrued any liabilities for this matter as of March 31, 2020. As of the filing of this Report, there has been no further update regarding this matter. COVID-19 On March 11, 2020, the World Health Organization announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, the U.S. President announced a National Emergency relating to the disease. There is a possibility of continued widespread infection in the United States and abroad, with the potential for catastrophic impact. National, state and local authorities have required or recommended social distancing and imposed quarantine and isolation measures on large portions of the population, including mandatory business closures. These measures, while intended to protect human life, have had, and may continue to have, serious adverse impacts on domestic and foreign economies of uncertain severity and duration. On June 8, 2020, the National Bureau of Economic Research indicated that the U.S. economy had entered a recession. The sweeping nature of the coronavirus pandemic makes it extremely difficult to predict how the Company’s business and operations will be affected in the longer run, but we expect that it may materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. Moreover, the coronavirus outbreak has begun to have indeterminable adverse effects on general commercial activity and the world economy, and our business and results of operations could be adversely affected to the extent that this coronavirus or any other epidemic harms the global economy generally and/or the markets in which we operate specifically. Any of the foregoing factors, or other cascading effects of the coronavirus pandemic that are not currently foreseeable, could materially increase our costs, negatively impact our revenues and damage the Company’s results of operations and its liquidity position, possibly to a significant degree. The duration of any such impacts cannot be predicted. As discussed in Note 14 - Subsequent Events , an existing major customer of the Company suspended certain professional services we provided to the customer effective April 30, 2020 due to COVID-19. These services accounted for $0.5 million , or 13% , of the Company’s revenue for the three months ended March 31, 2020. Uncertainties resulting from COVID-19 may result in additional customers delaying budget expenditures or re-allocating resources, which would result in a decrease in orders from these customers. Any such decrease in orders from these customers could cause a material adverse effect on our revenues and financial results and our ability to generate positive cash flows, all of which cannot be predicted at this time.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 14 - Subsequent Events Paycheck Protection Program Loan On April 10, 2020 (the “Origination Date”), the Company received $2,416,600 in aggregate loan proceeds (the “PPP Loan”) from MidFirst Bank (the “Lender”) pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The Loan is evidenced by a Promissory Note (the “Note”), dated April 10, 2020, by and between the Company and the Lender. Subject to the terms of the Note, the Loan bears interest at a fixed rate of one percent ( 1.0% ) per annum. Payments of principal and interest are deferred for the first six months following the Origination Date. Following the deferral period, the Company will be required to make payments of principal plus interest accrued under the Loan to the Lender in 18 monthly installments based upon an amortization schedule to be determined by the Lender based on the principal balance of the Note outstanding following the deferral period and taking into consideration any portion of the Loan that is forgiven prior to that time. The Loan is unsecured and guaranteed by the U.S. Small Business Administration. The Company may apply to the Lender for forgiveness of some or all of the Loan, with the amount which may be forgiven equal to the sum of eligible payroll costs, mortgage interest, covered rent, and covered utility payments, in each case incurred by the Company during the twenty four-week period following the Origination Date, calculated in accordance with the terms of the CARES Act. Certain reductions in Company payroll costs during this period may reduce the amount of the Loan eligible for forgiveness. There is no guarantee that the Company will receive forgiveness for any fixed amount of any Loan principal received by the Company. The Note provides for customary events of default including, among other things, failure to make any payment when due, cross-defaults under any loan documents with the Lender, certain cross-defaults under agreements with third parties, inaccuracy of representations and warranties, events of dissolution or insolvency, certain change of control events, and material adverse changes in the Company’s financial condition. If an event of default occurs, the Lender will have the right to accelerate indebtedness under the Loan and/or pursue other remedies available to the Lender at law or in equity. Suspension of Services by Major Customer An existing major customer of Oblong Industries suspended certain professional services we provide to this customer effective April 30, 2020 due to the novel Coronavirus (COVID-19). These services accounted for $549,000 of the Company’s revenue during the three months ended March 31, 2020, which represented 10% of the Company’s revenue for this period. These services were not related to the Company’s Mezzanine product and service offering. It is uncertain whether this customer will resume these services later in 2020 or in the future. SVB Loan Agreement The SVB Loan Agreement originally provided that interest-only payments were due through March 31, 2020, after which equal monthly principal and interest payments were payable in order to fully repay the loan by September 1, 2021. As discussed in Note 8 - Debt , on June 26, 2020, the Company and SVB entered into a Default Waiver and First Amendment (the “Amendment”) to the SVB Loan Agreement. Under the Amendment, the Bank has agreed to waive the Company’s failure to comply with certain covenants set forth in the Loan Agreement as well as certain events which could be deemed to constitute events of default under the Loan Agreement, including Borrowers’ failure to timely pay principal payments due April 1, 2020, May 1, 2020 and June 1, 2020, as well as a $100,000 deferral fee due April 1, 2020. Payment of each of these amounts was previously deferred pursuant to verbal and/or email communications between representatives of the Company and the Bank pending negotiation of the Amendment. In addition, among other things, the Amendment amends the Loan Agreement to: (1) extend the interest-only payment period under the Loan Agreement through September 30, 2020, and provide for payment of principal and interest over an eighteen month period from October 1, 2020 through March 1, 2022; (2) extend the maturity date of the Loan Agreement from September 1, 2021 to March 1, 2022; (3) change the due date for the previously existing $100,000 deferral fee from April 1, 2020 to the earlier of (i) the maturity of the loan, (ii) the repayment in full of all principal and interest owing under the Loan Agreement, and (iii) occurrence of an event of default under the Loan Agreement; and (4) increase the interest rate applying to principal outstanding under the SVB Loan Agreement from the Prime Rate (as defined in the SVB Loan Agreement) plus 2.0% , to the Prime Rate plus 4.25% .

Business Description and Sign_2

Business Description and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2019 . In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2019 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2019 and notes thereto included in the Company's fiscal 2019 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on May15, 2020 (the “ 2019 10-K”). The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. Because the closing of the acquisition of Oblong Industries occurred on October 1, 2019 , the Company’s condensed consolidated financial statements for the three months ended March 31, 2019 included in this Report do not reflect Oblong Industries’ financial results.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, Inc., and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.
Segments	Segments Prior to the acquisition of Oblong Industries on October 1, 2019 , the Company operated in one segment. Following October 1, 2019 , the former businesses of Glowpoint and Oblong Industries have been managed separately and involve different products and services. Accordingly, the Company currently operates in two segments: 1) the Glowpoint (now named Oblong) business which includes managed services for video collaboration and network applications and 2) the Oblong Industries business which includes products and services for visual collaboration technologies. See Note 12 - Segment Reporting for further discussion.
Use of Estimates	Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of property and equipment, and intangible assets, the inputs used in the fair value of equity based awards as well as the values ascribed to assets acquired and liabilities assumed in the business combination.
Leases	Leases The Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred.
Treasury Stock	Treasury Stock Purchases and sales of treasury stock are accounted for using the cost method. Under this method, shares acquired are recorded at the acquisition price directly to the treasury stock account. Upon sale, the treasury stock account is reduced by the original acquisition price of the shares and any difference is recorded in equity, on a first-in first-out basis. The Company does not recognize a gain or loss to income from the purchase and sale of treasury stock.
Recently Adopted Accounting Standards and Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02 “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” Topic 326 introduces an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g. accounts receivable, loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. Topic 326 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact the new guidance will have on its consolidated financial statements.

Oblong Industries Acquisition (

Oblong Industries Acquisition (Tables)	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Pro forma information	he Company's unaudited pro forma results for the three months ended March 31, 2019 are summarized in the table below, assuming the Acquisition had occurred on January 1, 2019. These unaudited pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the results of operations which would have actually resulted had the acquisition occurred on January 1, 2019, nor to be indicative of future results of operations. Pro forma and unaudited (as if the acquisition of Oblong Industries had occurred on January 1, 2019) Three Months Ended March 31, 2019 ($ in thousands) Revenue Glowpoint $ 2,594 Oblong Industries 4,718 Pro forma total revenue $ 7,312 Net loss Glowpoint $ (598 ) Oblong Industries (3,592 ) Pro forma net loss $ (4,190 )

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The activity in goodwill during the three months ended March 31, 2020 and the year ended December 31, 2019 is shown in the following table ($ in thousands): Goodwill Glowpoint Oblong Industries Total Balance December 31, 2018 $ 2,795 $ — $ 2,795 Impairment (2,254 ) — (2,254 ) Acquisition — 7,366 7,366 Balance December 31, 2019 541 7,366 7,907 Impairment (541 ) — (541 ) Balance March 31, 2020 $ — $ 7,366 $ 7,366

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of March 31, 2020 As of December 31, 2019 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Glowpoint Customer Relationships $ 4,335 $ (4,335 ) $ — $ 4,335 $ (4,335 ) $ — Affiliate network 994 (683 ) 311 994 (666 ) 328 Trademarks 548 (519 ) 29 548 (504 ) 44 Subtotal $ 5,877 $ (5,537 ) $ 340 $ 5,877 $ (5,505 ) $ 372 Oblong Industries Developed technology 10,060 (1,008 ) 9,052 10,060 (504 ) 9,556 Trade names 2,410 (120 ) 2,290 2,410 (60 ) 2,350 Distributor relationships 310 (31 ) 279 310 (16 ) 294 Subtotal $ 12,780 $ (1,159 ) $ 11,621 $ 12,780 $ (580 ) $ 12,200 Total $ 18,657 $ (6,696 ) $ 11,961 $ 18,657 $ (6,085 ) $ 12,572 The weighted average lives for the components of intangible assets are as follows: Glowpoint Affiliate network 12 Years Trademarks 8 Years Oblong Industries Developed technology 5 Years Trade names 10 Years Distributor relationships 5 Years
Schedule of Future Amortization Expense	Related amortization expense was $611,000 and $707,000 for the three months ended March 31, 2020 and the year ended December 31, 2019, respectively. Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2020 $ 1,820 2021 2,388 2022 2,386 2023 2,378 2024 1,844 Thereafter 1,145 Total $ 11,961

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	3 Months Ended
	Mar. 31, 2020
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): March 31, December 31, 2020 2019 Accrued compensation costs 596 810 Other accrued expenses and liabilities 661 843 Accrued dividends on Series A-2 Preferred Stock $ 5 $ 99 Accrued expenses and other liabilities $ 1,262 $ 1,752

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Debt consisted of the following (in thousands): March 31, December 31, 2020 2019 Loan obligations $ 5,609 $ 5,609 Unamortized debt discounts (68 ) (102 ) Net carrying value 5,541 5,507 Less: current maturities, net of debt discount (3,550 ) (2,664 ) Long-term obligations, net of current maturities and debt discount $ 1,991 $ 2,843

Stock Based Compensation (Table

Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Compensation Expense	Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended March 31, Three Months Ended March 31, 2020 2019 Research and development $ 14 $ — Sales and marketing 4 — General and administrative 8 — $ 26 $ —
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Options Granted, Exercised, Expired and Forfeited	A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019 is presented below: Outstanding Exercisable Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price Options outstanding, December 31, 2018 118,003 $ 19.90 118,003 $ 19.90 Exchanged for Oblong Industries stock options 107,845 4.92 Exercised — — Expired (440 ) 16.48 Forfeited (10,063 ) 23.20 Options outstanding, December 31, 2019 215,345 12.27 215,345 12.27 Options outstanding and exercisable, March 31, 2020 215,345 $ 12.27 215,345 $ 12.27
Shares Outstanding and Exercisable, By Exercise Price Range	Additional information as of March 31, 2020 is as follows: Outstanding and Exercisable Range of price Number of Options Weighted Average Remaining Contractual Life (In Years) Weighted Average Exercise Price $0.00 – $10.00 110,345 0.56 $ 5.01 $10.01 – $20.00 97,500 2.81 19.32 $20.01 – $30.00 2,500 2.19 21.80 $30.01 – $40.00 5,000 1.95 30.20 215,345 1.63 $ 12.27
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019, is presented below: Restricted Shares Weighted Average Grant Date Price Unvested restricted stock outstanding, December 31, 2018 11,320 $ 14.88 Granted 0 — Vested (1,372 ) 15.72 Forfeited (9,321 ) 14.70 Unvested restricted stock outstanding, December 31, 2019 627 15.80 Unvested restricted stock outstanding, March 31, 2020 627 $ 15.80
Schedule of Compensation Expense	Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands): Three Months Ended March 31, Three Months Ended March 31, 2020 2019 General and administrative — 2 $ — $ 2
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019, is presented below: Restricted Stock Units Weighted Average Grant Price Unvested restricted stock units outstanding, December 31, 2018 503,518 $ 1.94 Granted 55,479 1.30 Vested (114,505 ) 3.05 Forfeited (421,158 ) 1.54 Unvested restricted stock units outstanding, December 31, 2019 23,334 2.20 Unvested restricted stock units outstanding, March 31, 2020 23,334 $ 2.20
Schedule of Compensation Expense	Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands): Three Months Ended March 31, Three Months Ended March 31, 2020 2019 Cost of revenue $ — $ 4 Research and development — 4 Sales and marketing — 19 General and administrative 6 27 $ 6 $ 54

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended March 31, 2020 2019 Numerator: Net loss $ (3,129 ) $ (598 ) Less: preferred stock dividends (4 ) (15 ) Net loss attributable to common stockholders $ (3,133 ) $ (613 ) Denominator: Weighted-average number of shares of common stock for diluted net loss per share 5,204 5,104 Basic and diluted net loss per share $ (0.60 ) $ (0.12 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Three Months Ended March 31, 2020 2019 Unvested restricted stock units 23,334 539,394 Outstanding stock options 215,345 117,902 Unvested restricted stock awards 627 11,318 Shares of common stock issuable upon conversion of Series A-2 preferred stock 10,978 79,043 Shares of common stock issuable upon conversion of Series C preferred stock 108,333 158,333 Shares of common stock issuable upon conversion of Series D preferred stock 1,720,460 — Shares of common stock issuable upon conversion of Series E preferred stock 1,315,790 — Warrants 72,394 —

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Concentration of revenues was as follows: Three Months ended March 31, 2020 2019 Segment % of Revenue % of Revenue Customer A Glowpoint 11 % 21 % Customer B Glowpoint * 28 % Customer C Glowpoint * 10 % Customer D Oblong Industries 22 % — % * The amount did not exceed 10% of the Company’s consolidated total revenues. Concentration of accounts receivable was as follows: Three Months ended March 31, 2020 2019 Segment % of Accounts Receivable % of Accounts Receivable Customer A Glowpoint * 11 % Customer B Glowpoint * 48 % Customer C Glowpoint * * Customer D Glowpoint * 15 % Customer E Oblong Industries 42 % — % Customer F Oblong Industries 11 % — % * The amount did not exceed 10% of the Company’s consolidated total accounts receivable. Certain information concerning the Company’s segments for the three months ended March 31, 2020 is presented in the following tables (in thousands): Three Months ended March 31, 2020 Glowpoint Oblong Industries Total Revenue $ 2,045 $ 3,283 $ 5,328 Cost of revenues 1,156 1,218 2,374 Gross profit $ 889 $ 2,065 $ 2,954 Gross profit % 43 % 63 % 55 % Allocated operating expenses $ 1,290 $ 2,073 $ 3,363 Unallocated operating expenses — — 2,568 Total operating expenses $ 1,290 $ 2,073 $ 5,931 Loss from operations $ (401 ) $ (8 ) $ (2,977 ) Interest and other expense, net — — (152 ) Net loss $ (401 ) $ (8 ) $ (3,129 ) As of March 31, 2020 Total assets $ 3,743 $ 28,210 $ 31,953
Revenue from External Customers by Geographic Areas	Revenue by geographic area is allocated as follows (in thousands): Three Months ended March 31, 2020 2019 Domestic $ 3,602 $ 1,796 Foreign 1,726 798 $ 5,328 $ 2,594
Schedule of Disaggregated Revenue Information	Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months ended March 31, 2020 % of Revenue 2019 % of Revenue Revenue: Glowpoint Video collaboration services $ 1,046 20 % $ 1,566 60 % Network services 925 17 % 965 37 % Professional and other services 74 1 % 63 2 % Total Glowpoint revenue $ 2,045 38 % $ 2,594 100 % Revenue: Oblong Industries Visual collaboration product offerings $ 2,322 44 % $ — — % Professional services 669 13 % — — % Licensing 292 5 % — — % Total Oblong Industries revenue $ 3,283 62 % $ — — % Total revenue $ 5,328 100 % $ 2,594 100 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Balance sheet information	The following provides balance sheet information related to leases as of March 31, 2020 (in thousands): March 31, 2020 Assets Operating lease, right-of-use assets $ 2,602 Liabilities Operating lease liabilities, current $ 1,294 Operating lease liabilities, non-current 1,487 Total operating lease liabilities $ 2,781
Schedule of Future Minimum Rental Payments for Operating Leases	The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2020 $ 981 2021 1,169 2022 716 2023 117 Total cash payments remaining $ 2,983 Effect of discounting (202 ) Total lease liability $ 2,781

Business Description and Sign_3

Business Description and Significant Accounting Policies (Details) - segment	Oct. 01, 2019	Mar. 31, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Number of operating segments	1	2	1

Liquidity and Going Concern U_2

Liquidity and Going Concern Uncertainty (Details) - USD ($)	Jun. 26, 2020	Apr. 10, 2020	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Oct. 01, 2019	Dec. 31, 2018
Line of Credit Facility [Line Items]
Cash			$ 2,059,000	$ 4,602,000	$ 1,589,000		$ 2,007,000
Working capital			(895,000)
Net loss			3,129,000		598,000
Net cash used in operating activities			2,536,000		$ 408,000
Decrease in operating expenses			$ 1,081,000
Decrease in operating expenses, percentage			19.00%
Operating expenses			$ 4,575,000	$ 5,656,000
Term Loan Facility | SVB Loan Agreement
Line of Credit Facility [Line Items]
Term loan facility						$ 5,247,000
Subsequent Events | PPP Loan
Line of Credit Facility [Line Items]
Proceeds from issuance of debt		$ 2,416,600
Debt term		2 years
Fixed rate		1.00%
Subsequent Events | Term Loan Facility | SVB Loan Agreement, Amendment
Line of Credit Facility [Line Items]
Principal payment	$ 291,500

Oblong Industries Acquisition -

Oblong Industries Acquisition - Additional Information (Details) - USD ($) $ in Thousands	Oct. 01, 2019	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Goodwill		$ 7,366	$ 7,907	$ 2,795
Oblong Industries
Business Acquisition [Line Items]
Purchase price	$ 18,862
Assets acquired	11,496
Intangible assets acquired	12,780
Goodwill	$ 7,366	$ 7,366

Oblong Industries Acquisition_2

Oblong Industries Acquisition - Pro Forma (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenue		$ 7,312
Pro forma net loss		(4,190)
Oblong Industries
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Revenue from acquiree	$ 3,283
Net loss from acquiree	$ 2,234
Total revenue		4,718
Pro forma net loss		(3,592)
Glowpoint
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenue		2,594
Pro forma net loss		$ (598)

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Inventory	$ 1,439	$ 1,816

Goodwill - Narrative (Details)

Goodwill - Narrative (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)reporting_unit	Dec. 31, 2019USD ($)	Oct. 01, 2019USD ($)	Dec. 31, 2018USD ($)
Goodwill [Line Items]
Goodwill	$ 7,366	$ 7,907		$ 2,795
Number of reporting units | reporting_unit	2
Impairment loss	$ 541	2,254
Glowpoint
Goodwill [Line Items]
Goodwill	0	541	$ 541	$ 2,795
Impairment loss	541	$ 2,254
Oblong Industries
Goodwill [Line Items]
Goodwill	$ 7,366		$ 7,366

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Intangible assets, gross	$ 18,657	$ 18,657
Accumulated amortization	(6,696)	(6,085)
Total	11,961	12,572
Glowpoint
Business Acquisition [Line Items]
Intangible assets, gross	5,877	5,877
Accumulated amortization	(5,537)	(5,505)
Total	340	372
Glowpoint | Customer/Distributer relationships
Business Acquisition [Line Items]
Intangible assets, gross	4,335	4,335
Accumulated amortization	(4,335)	(4,335)
Total	0	0
Glowpoint | Affiliate network
Business Acquisition [Line Items]
Intangible assets, gross	994	994
Accumulated amortization	(683)	(666)
Total	$ 311	328
Estimated Useful Life	12 years
Glowpoint | Trademarks
Business Acquisition [Line Items]
Intangible assets, gross	$ 548	548
Accumulated amortization	(519)	(504)
Total	$ 29	44
Estimated Useful Life	8 years
Oblong Industries
Business Acquisition [Line Items]
Intangible assets, gross	$ 12,780	12,780
Accumulated amortization	(1,159)	(580)
Total	11,621	12,200
Oblong Industries | Customer/Distributer relationships
Business Acquisition [Line Items]
Intangible assets, gross	310	310
Accumulated amortization	(31)	(16)
Total	$ 279	294
Estimated Useful Life	5 years
Oblong Industries | Developed technology
Business Acquisition [Line Items]
Intangible assets, gross	$ 10,060	10,060
Accumulated amortization	(1,008)	(504)
Total	$ 9,052	9,556
Estimated Useful Life	5 years
Oblong Industries | Trade names
Business Acquisition [Line Items]
Intangible assets, gross	$ 2,410	2,410
Accumulated amortization	(120)	(60)
Total	$ 2,290	$ 2,350
Estimated Useful Life	10 years

Goodwill - Schedule of Goodwill

Goodwill - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Goodwill [Roll Forward]
Beginning balance	$ 7,907	$ 2,795
Impairment	(541)	(2,254)
Acquisition		7,366
Ending balance	7,366	7,907
Glowpoint
Goodwill [Roll Forward]
Beginning balance	541	2,795
Impairment	(541)	(2,254)
Acquisition		0
Ending balance	0	541
Oblong Industries
Goodwill [Roll Forward]
Beginning balance	7,366	0
Impairment	0	0
Acquisition		7,366
Ending balance	$ 7,366	$ 7,366

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Amortization expense	$ 611	$ 707
Minimum
Business Acquisition [Line Items]
Intangible assets, estimated useful life	5 years
Maximum
Business Acquisition [Line Items]
Intangible assets, estimated useful life	12 years

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2020	$ 1,820
2021	2,388
2022	2,386
2023	2,378
2024	1,844
Thereafter	1,145
Total	$ 11,961	$ 12,572

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Other Liabilities Disclosure [Abstract]
Accrued compensation costs	$ 596	$ 810
Other accrued expenses	661	843
Accrued dividends on Series A-2 Preferred Stock	5	99
Accrued expenses and other liabilities	$ 1,262	$ 1,752

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Unamortized debt discounts	$ (68)	$ (102)
Net carrying value	5,541	5,507
Less: current maturities, net of debt discount	(3,550)	(2,664)
Long-term obligations, net of current maturities and debt discount	1,991	2,843
Loan obligations
Debt Instrument [Line Items]
Long-term debt	$ 5,609	$ 5,609

Debt - SVB Agreement (Details)

Debt - SVB Agreement (Details)	Jun. 26, 2020USD ($)	Oct. 01, 2019USD ($)$ / sharesshares	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Mar. 31, 2019USD ($)
Debt Instrument [Line Items]
Amortization of debt discount			$ 34,000		$ 0
Debt instrument, unamortized discount			68,000	$ 102,000
SVB Loan Agreement
Debt Instrument [Line Items]
Outstanding principal, debt obligations			$ 5,609,000	$ 5,609,000
Term Loan Facility | SVB Loan Agreement
Debt Instrument [Line Items]
Face amount		$ 5,247,000
Effective percentage			5.25%	6.75%
Fee amount		192,000
Debt issuance costs		$ 20,000
Amortization of debt discount			$ 34,000	$ 90,000
Debt instrument, unamortized discount			68,000	$ 102,000
Term Loan Facility | SVB Loan Agreement | Prime Rate
Debt Instrument [Line Items]
Basis spread		2.00%
SVB Warrant
Debt Instrument [Line Items]
Number of warrants called | shares		72,394
Exercise price (in dollars per share) | $ / shares		$ 0.01
Warrant term		10 years
Deferral Fee | Term Loan Facility | SVB Loan Agreement
Debt Instrument [Line Items]
Fee amount		$ 100,000
Maturity Fee | Term Loan Facility | SVB Loan Agreement
Debt Instrument [Line Items]
Fee amount		$ 262,000
Risk Free Interest Rate | SVB Warrant
Debt Instrument [Line Items]
Warrant measurement input		0.015
Expected Volatility | SVB Warrant
Debt Instrument [Line Items]
Warrant measurement input		1.43
Additional Paid-In Capital
Debt Instrument [Line Items]
Issuance of warrants to purchase common stock in connection with long term debt			$ 72,000
Subsequent Events | Term Loan Facility | SVB Loan Agreement, Amendment
Debt Instrument [Line Items]
Principal payment	$ 291,500
Subsequent Events | Term Loan Facility | SVB Loan Agreement, Amendment | Prime Rate
Debt Instrument [Line Items]
Basis spread	4.25%

Preferred Stock (Details)

Preferred Stock (Details) - USD ($)	Oct. 01, 2019	Jan. 25, 2018	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Jan. 31, 2018
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			5,000,000
Accrued dividends on Series A-2 Preferred Stock			$ 5,000		$ 99,000
Issue of preferred stock in exchange for accrued dividends			$ 98,000	$ 0
Common stock, shares outstanding (in shares)			5,211,543		5,161,543
Common Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			50,000	43,402
Issuance of restricted stock (in shares)				16,824
Perpetual Series B-1 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			100
Preferred stock, shares issued (in shares)			0
Preferred stock, shares outstanding (in shares)			0
Series A-2 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			7,500		7,500
Preferred stock, shares issued (in shares)			45		32
Preferred stock, shares outstanding (in shares)			45		32
Preferred stock percentage			5.00%
Preferred stock, stated value			$ 7,500		$ 7,500
Stock issued during period, conversion of convertible securities, price (in dollars per share)			$ 21.60		$ 21.60
Convertible preferred stock, shares issued upon conversion (in shares)			10,978
Accrued dividends on Series A-2 Preferred Stock			$ 5,000		$ 99,000
Redemption price per share (in dollars per share)			$ 8,250
Redemption price per share, multiplier (in dollars per share)			$ 7,500
Redemption price per share, multiplier, percentage			110.00%
Preferred stock, convertible, par value (in dollars per share)			$ 0.0001		$ 0.0001
Conversion of convertible preferred stock, shares (in shares)			13
Conversion price below the fair value of common stock (in dollars per share)					$ 11.16
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			2,800
Preferred stock, shares issued (in shares)			0
Preferred stock, shares outstanding (in shares)			0
Preferred stock percentage			0.00%
Series B Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)				75
Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			1,750		1,750
Preferred stock, shares issued (in shares)			325		475
Preferred stock, shares outstanding (in shares)			325		475
Preferred stock percentage			0.00%
Preferred stock, stated value			$ 1,000		$ 1,000
Stock issued during period, conversion of convertible securities, price (in dollars per share)						$ 3
Proceeds from issuance of preferred stock gross		$ 1,750,000
Preferred stock, convertible, par value (in dollars per share)		$ 1,000	$ 0.0001		$ 0.0001
Series C Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			150	50	50
Series C Preferred Stock | Common Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			50,000		16,667
Series D Convertible Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			4,000
Preferred stock, shares issued (in shares)			0
Preferred stock, shares outstanding (in shares)			0
Perpetual Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			100
Preferred stock, shares issued (in shares)			0
Preferred stock, shares outstanding (in shares)			0
Series D Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			1,750,000		1,750,000
Preferred stock, shares issued (in shares)			1,720,460		1,734,901
Preferred stock, shares outstanding (in shares)			1,720,460		1,734,901
Preferred stock percentage			6.00%
Preferred stock, stated value	$ 28.50		$ 28.50		$ 28.50
Convertible preferred stock, shares issued upon conversion (in shares)			17,204,600
Preferred stock, convertible, par value (in dollars per share)			$ 0.0001		$ 0.0001
Conversion of convertible preferred stock, shares (in shares)	1,686,659
Conversion price (in dollars per share)	$ 2.85
Series E Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			175,000		175,000
Preferred stock, shares issued (in shares)			131,579		131,579
Preferred stock, shares outstanding (in shares)			131,579		131,579
Preferred stock percentage			6.00%
Preferred stock, stated value			$ 28.50		$ 28.50
Convertible preferred stock, shares issued upon conversion (in shares)					1,315,790
Preferred stock, convertible, par value (in dollars per share)			$ 0.0001		$ 0.0001
Restricted Stock | Series D Preferred Stock
Class of Stock [Line Items]
Issuance of restricted stock (in shares)	49,967
Vesting period	2 years
Series E Financing | Series E Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)	1,315,790
Sale fo stock consideration received	$ 3,750,000
Sale of stock, price per share	$ 28.50
Maximum | Series E Financing | Series E Preferred Stock
Class of Stock [Line Items]
Issuance of stock	131,579
Plan
Class of Stock [Line Items]
Common stock, shares outstanding (in shares)			23,731,933

Stock Based Compensation - Narr

Stock Based Compensation - Narrative (Details) - USD ($)	Oct. 01, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 19, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding (in shares)		215,345		215,345		118,003
Number of options granted (in shares)				107,845
Options, intrinsic value, vested		$ 0
Unrecognized stock-based compensation expense for stock options		0
Stock-based compensation, tax benefit		0
Compensation costs capitalized as part of the cost of an asset		$ 0		$ 0
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)		0
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, restricted shares (in shares)				0
Unvested restricted shares outstanding (in shares)		627		627		11,320
Stock option compensation expense		$ 0	$ 2,000
Forfeited, restricted shares (in shares)				9,321
Unrecognized stock-based compensation expense for other than options		$ 0
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, restricted shares (in shares)				55,479
Unvested restricted shares outstanding (in shares)		23,334		23,334		503,518
Stock option compensation expense		$ 6,000	$ 0
Forfeited, restricted shares (in shares)				421,158
Unrecognized stock-based compensation expense for other than options		$ 0
Stock-based compensation arrangement, vested in period, remain outstanding (in shares)		28,904	98,763
Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		11,667
Time-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		11,667
Prior Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)					421,000
2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		3,021,000
Awards granted in period (in shares)		0
2019 Equity Incentive Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		2,600,000
2007 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		0
2007 Stock Incentive Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding (in shares)		107,500
2007 Stock Incentive Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		627
Nonemployee | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	107,845
Weighted average price of shares (in dollars per share)	$ 4.92
Exercise period	1 year
Stock option compensation expense				$ 0
Series D Preferred Stock | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		1,720,460
Stock option compensation expense		$ 26,000	$ 0
Forfeited, restricted shares (in shares)		14,441
Unrecognized stock-based compensation expense for other than options		$ 319,000
Weighted average period for amortization of unrecognized stock-based compensation		1 year 2 months 9 days
Issuance of restricted stock (in shares)	49,967
Vesting period	2 years

Stock Based Compensation - Opti

Stock Based Compensation - Options Outstanding (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Number of Options
Outstanding Number of Options, Beginning (in shares)	215,345	118,003
Outstanding Number of Options, Exchanged for Oblong Industries stock options (in shares)		107,845
Outstanding Number of Options, Exercised (in shares)		0
Outstanding Number of Options, Expired (in shares)		(440)
Outstanding Number of Options, Forfeited (in shares)		(10,063)
Outstanding and Exercisable Number of Options, Ending (in shares)	215,345	215,345
Weighted Average Exercise Price
Outstanding Weighted Average Exercise Price, Beginning (in dollars per share)	$ 12.27	$ 19.90
Outstanding Weighted Average Exercise Price, Exchanged for Oblong Industries stock options (in dollars per share)		4.92
Outstanding Weighted Average Exercise Price, Exercised (in dollars per share)		0
Outstanding Weighted Average Exercise Price, Expired (in dollars per share)		16.48
Outstanding Weighted Average Exercise Price, Forfeited (in dollars per share)		23.20
Outstanding and Exercisable Weighted Average Exercise Price, Ending (in dollars per share)	$ 12.27	$ 12.27
Exercisable
Exercisable Number of Options, Beginning (in shares)	215,345	118,003
Exercisable Number of Options, Ending (in shares)	215,345	215,345
Exercisable Weighted Average Exercise Price, Beginning (in dollars per share)	$ 12.27	$ 19.90
Exercisable Weighted Average Exercise Price, Ending (in dollars per share)	$ 12.27	$ 12.27

Stock Based Compensation - Exer

Stock Based Compensation - Exercise Price Range (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options, Outstanding and Exercisable (in shares)	215,345	215,345	118,003
Weighted Average Remaining Contractual Life (In Years)	1 year 7 months 17 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 12.27	$ 12.27	$ 19.90
$0.00 – $10.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	0
Range of price, upper range limit (in dollars per share)	$ 10
Number of Options, Outstanding and Exercisable (in shares)	110,345
Weighted Average Remaining Contractual Life (In Years)	6 months 22 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 5.01
$10.01 – $20.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	10.01
Range of price, upper range limit (in dollars per share)	$ 20
Number of Options, Outstanding and Exercisable (in shares)	97,500
Weighted Average Remaining Contractual Life (In Years)	2 years 9 months 22 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 19.32
$20.01 – $30.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	20.01
Range of price, upper range limit (in dollars per share)	$ 30
Number of Options, Outstanding and Exercisable (in shares)	2,500
Weighted Average Remaining Contractual Life (In Years)	2 years 2 months 9 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 21.80
$30.01 – $40.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	30.01
Range of price, upper range limit (in dollars per share)	$ 40
Number of Options, Outstanding and Exercisable (in shares)	5,000
Weighted Average Remaining Contractual Life (In Years)	1 year 11 months 12 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 30.20

Stock Based Compensation - Rest

Stock Based Compensation - Restricted Stock Activity (Details) - Restricted Stock - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Restricted Shares
Unvested restricted shares outstanding, Beginning (in shares)	627	11,320
Granted, restricted shares (in shares)		0
Vested, restricted shares (in shares)		(1,372)
Forfeited, restricted shares (in shares)		(9,321)
Unvested restricted shares outstanding, Ending (in shares)	627	627
Weighted Average Grant Price
Unvested restricted shares, weighted average grant price, Beginning (in dollars per share)	$ 15.80	$ 14.88
Granted, weighted average grant price (in dollars per share)		0
Vested, weighted average grant price (in dollars per share)		15.72
Forfeited, weighted average grant price (in dollars per share)		14.70
Unvested restricted shares, weighted average grant price, Ending (in dollars per share)	$ 15.80	$ 15.80

Stock Based Compensation - Stoc

Stock Based Compensation - Stock Compensation Expense, Restricted Stock (Details) - Restricted Stock - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 2
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 2

Stock Based Compensation - Re_2

Stock Based Compensation - Restricted Stock Unit Activity (Details) - RSUs - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Restricted Stock Units
Unvested restricted shares outstanding, Beginning (in shares)	23,334	503,518
Granted, restricted shares (in shares)		55,479
Vested, restricted shares (in shares)		(114,505)
Forfeited, restricted shares (in shares)		(421,158)
Unvested restricted shares outstanding, Ending (in shares)	23,334	23,334
Weighted Average Grant Price
Unvested restricted shares, weighted average grant price, Beginning (in dollars per share)	$ 2.20	$ 1.94
Granted, weighted average grant price (in dollars per share)		1.30
Vested, weighted average grant price (in dollars per share)		3.05
Forfeited, weighted average grant price (in dollars per share)		1.54
Unvested restricted shares, weighted average grant price, Ending (in dollars per share)	$ 2.20	$ 2.20

Stock Based Compensation - St_2

Stock Based Compensation - Stock Compensation Expense, Restricted Stock Units (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 2
Restricted Stock | General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	2
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	6	0
RSUs | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0
RSUs | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0
RSUs | Selling and Marketing Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	0	0
RSUs | General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	6	0
Series D Preferred Stock | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	26	0
Series D Preferred Stock | Restricted Stock | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	14	0
Series D Preferred Stock | Restricted Stock | Selling and Marketing Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	4	0
Series D Preferred Stock | Restricted Stock | General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 8	$ 0

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Earnings Per Share [Abstract]
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)	0
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average number of shares, vested (in shares)	28,904	98,763
Unvested restricted shares outstanding (in shares)	23,334		23,334	503,518

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator:
Net loss	$ (3,129)	$ (598)
Less: preferred stock dividends	(4)	(15)
Net loss attributable to common stockholders	$ (3,133)	$ (613)
Denominator:
Weighted-average number of shares of common stock for diluted net loss per share	5,204
Weighted-average number of shares of common stock for basic and diluted net loss per share (in shares)	5,204	5,104
Basic and diluted net loss per share (in dollars per share)	$ (0.60)	$ (0.12)

Net Loss Per Share - Effect of

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	23,334	539,394
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	215,345	117,902
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	627	11,318
Series A-2 Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	10,978	79,043
Series C Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	108,333	158,333
Series D Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,720,460	0
Series E Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,315,790	0
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	72,394	0

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	Oct. 01, 2019segment	Mar. 31, 2020USD ($)segment	Mar. 31, 2019USD ($)	Sep. 30, 2019segment	Dec. 31, 2019USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	1	2		1
Revenue		$ 5,328	$ 2,594
Cost of revenue (exclusive of depreciation and amortization)		2,374	1,675
Gross profit		$ 2,954	919
Gross profit %		55.00%
Total operating expenses		$ 5,931	1,517
Loss from operations		(2,977)	(598)
Interest and other (income) expense, net		152	0
Net loss		(3,129)	(598)
Total assets		31,953			$ 34,909
Glowpoint
Segment Reporting Information [Line Items]
Revenue		2,045	2,594
Cost of revenue (exclusive of depreciation and amortization)		1,156
Gross profit		$ 889
Gross profit %		43.00%
Total operating expenses		$ 1,290
Loss from operations		(401)
Interest and other (income) expense, net		0
Net loss		(401)
Total assets		3,743
Oblong Industries
Segment Reporting Information [Line Items]
Revenue		3,283	0
Cost of revenue (exclusive of depreciation and amortization)		1,218
Gross profit		$ 2,065
Gross profit %		63.00%
Total operating expenses		$ 2,073
Loss from operations		(8)
Interest and other (income) expense, net		0
Net loss		(8)
Total assets		28,210
Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses		3,363
Allocated operating expenses | Glowpoint
Segment Reporting Information [Line Items]
Total operating expenses		1,290
Allocated operating expenses | Oblong Industries
Segment Reporting Information [Line Items]
Total operating expenses		2,073
Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses		2,568
Unallocated operating expenses | Glowpoint
Segment Reporting Information [Line Items]
Total operating expenses		0
Unallocated operating expenses | Oblong Industries
Segment Reporting Information [Line Items]
Total operating expenses		0
Domestic
Segment Reporting Information [Line Items]
Revenue		3,602	1,796
Foreign
Segment Reporting Information [Line Items]
Revenue		$ 1,726	$ 798

Segment Reporting - Disaggregat

Segment Reporting - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Revenue	$ 5,328	$ 2,594
Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	100.00%	100.00%
Glowpoint
Disaggregation of Revenue [Line Items]
Revenue	$ 2,045	$ 2,594
Glowpoint | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	38.38%	100.00%
Glowpoint | Assets
Disaggregation of Revenue [Line Items]
Percentage of revenue	100.00%		100.00%
Glowpoint | Video collaboration services
Disaggregation of Revenue [Line Items]
Revenue	$ 1,046	$ 1,566
Glowpoint | Video collaboration services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	19.63%	60.37%
Glowpoint | Network services
Disaggregation of Revenue [Line Items]
Revenue	$ 925	$ 965
Glowpoint | Network services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	17.36%	37.20%
Glowpoint | Professional and other services
Disaggregation of Revenue [Line Items]
Revenue	$ 74	$ 63
Glowpoint | Professional and other services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	1.39%	2.43%
Oblong Industries
Disaggregation of Revenue [Line Items]
Revenue	$ 3,283	$ 0
Oblong Industries | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	62.00%	0.00%
Oblong Industries | Video collaboration services
Disaggregation of Revenue [Line Items]
Revenue	$ 2,322	$ 0
Oblong Industries | Video collaboration services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	43.58%
Oblong Industries | Professional and other services
Disaggregation of Revenue [Line Items]
Revenue	$ 669	$ 0
Oblong Industries | Professional and other services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	12.56%	0.00%
Oblong Industries | Licensing
Disaggregation of Revenue [Line Items]
Revenue	$ 292	$ 0
Oblong Industries | Licensing | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	5.48%	0.00%
Domestic
Disaggregation of Revenue [Line Items]
Revenue	$ 3,602	$ 1,796
Domestic | Oblong Industries | Assets
Disaggregation of Revenue [Line Items]
Percentage of revenue	81.00%
Foreign
Disaggregation of Revenue [Line Items]
Revenue	$ 1,726	$ 798
Foreign | Oblong Industries | Assets
Disaggregation of Revenue [Line Items]
Percentage of revenue	19.00%

Segment Reporting - Concentrati

Segment Reporting - Concentration Percentage (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue
Concentration Risk [Line Items]
Concentration risk percentage	100.00%	100.00%
Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	38.38%	100.00%
Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	62.00%	0.00%
Customer A | Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	21.00%
Customer A | Glowpoint | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage		11.00%
Customer B | Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage		28.00%
Customer B | Glowpoint | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage		48.00%
Customer C | Glowpoint | Revenue
Concentration Risk [Line Items]
Concentration risk percentage		10.00%
Customer D | Glowpoint | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage		15.00%
Customer D | Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	22.00%	0.00%
Customer E | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage	42.00%	0.00%
Customer F | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	0.00%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Oct. 01, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
Non-cash lease expense	$ 316,000		$ 52,000
Operating lease - right of use asset, net	2,602,000	$ 3,117,000
Operating lease liability	2,781,000
Revenue	$ 5,328,000		$ 2,594,000
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease - right of use asset, net				$ 3,376,000	$ 99,000
Operating lease liability				$ 3,578,000	$ 111,000
Incremental borrowing rate				6.00%	7.75%
Minimum
Lessee, Lease, Description [Line Items]
Term of contract	1 year
Renewal term	12 months
Maximum
Lessee, Lease, Description [Line Items]
Term of contract	4 years
Renewal term	5 years
Professional and other services | Major Customer
Lessee, Lease, Description [Line Items]
Revenue	$ 549,000	$ 500,000
Revenue
Lessee, Lease, Description [Line Items]
Percentage of revenue	100.00%		100.00%
Revenue | Professional and other services | Major Customer
Lessee, Lease, Description [Line Items]
Percentage of revenue	10.00%	13.00%
Calculation Error | Adjustment
Lessee, Lease, Description [Line Items]
Operating lease - right of use asset, net	$ 195,000
Operating lease liability	$ 195,000

Commitments and Contingencies_2

Commitments and Contingencies - Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Operating lease - right of use asset, net	$ 2,602	$ 3,117
Operating lease liabilities, current	1,294	1,294
Operating lease liabilities, non-current	1,487	$ 2,020
Total operating lease liabilities	$ 2,781

Commitments and Contingencies_3

Commitments and Contingencies - Table Operating Lease Future Minimum Rental Commitment (Details) $ in Thousands	Mar. 31, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
2020	$ 981
2021	1,169
2022	716
2023	117
Total cash payments remaining	2,983
Effect of discounting	(202)
Total accrued lease liability	$ 2,781

Subsequent Events (Details)

Subsequent Events (Details)	Jun. 26, 2020	Apr. 10, 2020USD ($)installment	Oct. 01, 2019USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Mar. 31, 2019USD ($)
Subsequent Event [Line Items]
Revenue				$ 5,328,000		$ 2,594,000
Revenue
Subsequent Event [Line Items]
Percentage of revenue				100.00%		100.00%
Professional And Other Services [Member] | Major Customer
Subsequent Event [Line Items]
Revenue				$ 549,000	$ 500,000
Professional And Other Services [Member] | Major Customer | Revenue
Subsequent Event [Line Items]
Percentage of revenue				10.00%	13.00%
SVB Loan Agreement | Term Loan Facility
Subsequent Event [Line Items]
Fee amount			$ 192,000
SVB Loan Agreement | Term Loan Facility | Deferral Fee
Subsequent Event [Line Items]
Fee amount			$ 100,000
Subsequent Events | PPP Loan
Subsequent Event [Line Items]
Proceeds from issuance of debt		$ 2,416,600
Fixed rate		1.00%
Number of monthly installments | installment		18
Prime Rate | SVB Loan Agreement | Term Loan Facility
Subsequent Event [Line Items]
Basis spread			2.00%
Prime Rate | Subsequent Events | SVB Loan Agreement, Amendment | Term Loan Facility
Subsequent Event [Line Items]
Basis spread	4.25%